TMCnet2d
IMUNON Presents Positive Data from Phase 2 OVATION 2 Clinical Trial of IMNN-001 in Advanced Ovarian Cancer at SITC 39th Annual Meeting
As previously announced, IMUNON plans to hold an End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) in person to discuss the design for a Phase 3 pivotal study of IMNN-001 in ...
8 Of The Best Alternatives For Adobe Illustrator
Tired of paying for Adobe Illustrator's monthly subscription fees? Here are eight alternatives for anyone who needs vector ...